INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at Clover Health Investments Corp. Kaplan Fox & Kilsheimer LLP
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) Kaplan Fox & Kilsheimer LLP (
www.kaplanfox.com) is investigating claims on behalf of investors of Clover Health Investments Corp. (“Clover” or the “Company”) (NASDAQ: CLOV).
On February 4, 2021, Hindenburg Research published a report about Clover entitled Clover Health: How the King of SPACs Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation. The report claims Clover has not disclosed that its business model and its software offering, called the Clover Assistant, are under active investigation by the Department of Justice, which is investigating at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals. The report also accuses billionaire Chamath Palihapitiya of misleading investors of critical aspects of Cl
4 Min Read
(Reuters) - U.S. stocks extended their recent rally on Friday and the S&P 500 and Nasdaq indexes scored their biggest weekly percentage gains since the U.S. elections in early November, boosted by optimism over earnings, stimulus talks and progress on vaccine rollouts.
Both the Dow Jones industrial average and S&P 500 rose for a fifth straight session in their longest streak of gains since August, while the S&P 500 and Nasdaq posted record closing highs for a second day in a row.
A smaller-than-expected rebound in the U.S. labor market last month highlighted the need for more government aid to shore up the economy. The Labor Department on Friday reported a 49,000 increase in nonfarm payrolls last month, but job losses in manufacturing and construction.
Share this article
Share this article
NEW YORK, Feb. 5, 2021 /PRNewswire/ Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Clover Health Investments, Corp. (NASDAQ: CLOV).
On April 21, 2020, a blank check/special purpose acquisition vehicle called Social Capital Hedosophia Holdings Corp. III ( SCH ) had its IPO. SCH s securities were listed and traded under the symbols IPOC, IPOC.WS, and IPOC.U. On October 6, 2020, SCH announced it was going to merge with Clover Health Investments Corp. in a deal that valued Clover at a $3.7B enterprise value. The deal closed on January 7, 2021 and the company changed its name to Clover Health Investments, Corp. and its stock symbol to CLOV .
3 Min Read
(Reuters) - Shares in Clover Health Investments Corp ended a seesaw trading session higher on Friday after the first public comment by its backer, venture capitalist Chamath Palihapitiya, on a critical report by short-selling specialist Hindenburg Research.
Slideshow ( 2 images )
Clover said on Friday it would cooperate with an investigation by the U.S. Securities and Exchange Commission (SEC) into the Hindenburg report, which knocked Clover’s price down more than 12% on Thursday.
The selling continued on Friday but a rebound came in late trade after Palihapitiya tweeted that he wished Hindenburg had contacted him or Clover so that it could have evaluated things first hand. He said he will let Clover’s long-term goals and performance speak for themselves.
Short-seller Hindenburg Research turns up the heat on US insurance firm backed by GameStop Corp frenzy backer Chamath Palihapitiya proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.